Webinar - Evaluating Abuse Liabilities of New Drugs
A Translational Approach for Next Generation De-risking
We are pleased to invite you to Biotrial's new webinar.
Our Head of Development in Non-Clinical CNS Pharmacology, Simon Loiodice, Ph.D. and our CNS Medical Experts, Philippe Danjou, MD, PhD, and Jean-Louis Pinquier, MD, PhD, will cover:
• Current Drug Abuse Liability Assessments and their limits
• Biotrial's project relying on translational biomarkers reflecting drug-induced activation of reward pathways
Choose your region below to register and uncover the value this translational approach can bring to your next projects.
